(UroToday.com) In a podium presentation in the ESU-ESOU-ERUS session at the 19th Meeting of the EAU Section of Oncological Urology, Dr. Harke presented on complications following robotic assisted partial nephrectomy, along with their management. To begin, she highlighted the importance of a structured approach to assessing surgical complications. In 2004, Dindo published the classification of surgical […]
(UroToday.com) The 2022 EAU Section of Oncological Urology (ESOU) Annual Meeting included a session on locally advanced and oligometastatic prostate cancer and a presentation by Dr. Mary-Ellen Taplin discussing neoadjuvant treatments before radical prostatectomy for high-risk prostate cancer. Dr. Taplin notes that ~15% of patients present with localized high-risk prostate cancer, which may be life-threatening to […]
(UroToday.com) In a podium presentation in the ESU-ESOU-ERUS session at the 19th Meeting of the EAU Section of Oncological Urology, Dr. Nina Harke presented on considerations for choosing transperitoneal or retroperitoneal approaches for robotic partial nephrectomy. As is often done, she highlighted current guideline recommendations in this space. In Europe, the guidelines are non-comital with a […]
(UroToday.com) In a podium presentation in the ESU-ESOU-ERUS session at the 19th Meeting of the EAU Section of Oncological Urology, Dr. Andrea Minervini discussed functional results following partial nephrectomy. He began by emphasizing that the goal of nephron sparing surgery is to provide an oncologically rigorous operation with low perioperative morbidity and limited renal functional damage.
(UroToday.com) In a podium presentation in the ESU-ESOU-ERUS session at the 19th Meeting of the EAU Section of Oncological Urology, Dr. Andrea Minervini presented on the role of robotic partial nephrectomy for T1 and T1 renal tumors.
(UroToday.com) The 2022 EAU Section of Oncological Urology (ESOU) Annual Meeting included a session on the early detection and personalized management of testis cancer and a presentation by Dr. Asif Muneer discussing the management of indeterminate testicular masses. Dr. Muneer notes that the traditional dogma of testicular mass management is “when in doubt, take it out” […]
(UroToday.com) The 2022 EAU Section of Oncological Urology (ESOU) Annual Meeting included a session on the early detection and personalized management of testis cancer and a presentation by Dr. Robert Huddart discussing follow-up of early stage seminoma. Dr. Huddart notes that there are several reasons why we follow-up patients after treatment of testicular cancer, including detection […]
(UroToday.com) The 2022 EAU Section of Oncological Urology (ESOU) Annual Meeting included a session on the early detection and personalized management of testis cancer and a presentation by Dr. Sia Daneshmand discussing the role of retroperitoneal lymph node dissection (RPLND) in stage II seminoma. Chemotherapy or radiotherapy are standard treatments for stage II seminoma, though they […]
(UroToday.com) In a podium presentation in the Testis cancer Early detection and personalized management session at the 19th Meeting of the EAU Section of Oncological Urology, Dr. Fankhauser presented on the role of thromboprophylaxis in patients undergoing chemotherapy for metastatic germ cell tumors.
(UroToday.com) The 2022 EAU Section of Oncological Urology (ESOU) Annual Meeting included a session on urothelial cancer and a presentation by Dr. Alberto Breda discussing the utilization of en bloc resection in non-muscle invasive bladder cancer (NMIBC). En bloc resection of bladder tumors has been hypothesized to lead to better pathological specimens, shorter operative and catheterization […]
